WuXi to build dedicated vaccine facility, but who's the client?

WuXi Biologics says its vaccine joint venture has a new client and a 20-year arrangement it says should be worth about $3 billion. (WuXi Biologics).

0 items in Cart
Cart Subtotal:
Go to cart
You will be able to Pay Online or Request a Quote
Catalog
Services
Company